You are here: All Products  > Zai Lab's PARP Inhibitor Approved for First-Line Maintenance in Ovarian Cancer

Zai Lab's PARP Inhibitor Approved for First-Line Maintenance in Ovarian Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.